Amgen's total assets for Q2 2025 were $87.90B, a decrease of -1.64% from the previous quarter. AMGN total liabilities were $80.47B for the fiscal quarter, a -3.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.